(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-09 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1880950
Date | Daily Closing Price | Open | High | Low | Volume |
09 Mon Dec 2024 | 49.84 | 53.00 | 53.97 | 49.83 | 1.091 times |
26 Tue Nov 2024 | 49.31 | 50.00 | 50.63 | 48.49 | 0.633 times |
26 Tue Nov 2024 | 49.31 | 50.00 | 50.63 | 48.49 | 0.633 times |
25 Mon Nov 2024 | 50.40 | 49.21 | 51.73 | 48.89 | 1.182 times |
22 Fri Nov 2024 | 47.88 | 46.37 | 48.00 | 45.85 | 0.8 times |
21 Thu Nov 2024 | 46.29 | 47.21 | 47.21 | 45.51 | 1.114 times |
20 Wed Nov 2024 | 47.26 | 47.14 | 47.91 | 46.61 | 1.036 times |
19 Tue Nov 2024 | 46.97 | 46.97 | 47.53 | 46.56 | 0.812 times |
18 Mon Nov 2024 | 47.30 | 47.83 | 48.28 | 46.71 | 1.085 times |
15 Fri Nov 2024 | 47.25 | 47.61 | 48.44 | 46.30 | 1.666 times |
My analysis of stock is bullish for shortterm, and stock might move up till 51.6 or till 54.1. Use a stoploss of 49.5 and if this stock hits its stoploss, then it can fall down till 47.41
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 43.42 |
Downside Target | 44.44 |
Downside Target | 48.28 |
Downside Target | 49.83 |
Upside Target | 50.63 |
Upside Target | 51.73 |
Upside Target | 51.99 |
Upside Target | 53.97 |
Upside Target | 57.68 |
Upside Target | 59.07 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 48.46 |
Downside Intraday Target | 47.07 |
Upside Intraday Target | 52.6 |
Upside Intraday Target | 55.35 |
Upside Intraday Target | 51.21 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
09 Mon Dec 2024 | 49.84 | 53.00 | 53.97 | 49.83 | 1.725 times |
26 Tue Nov 2024 | 49.31 | 50.00 | 50.63 | 48.49 | 0.349 times |
26 Tue Nov 2024 | 49.31 | 49.21 | 51.73 | 48.49 | 0.375 times |
22 Fri Nov 2024 | 47.88 | 47.83 | 48.28 | 45.51 | 0.713 times |
15 Fri Nov 2024 | 47.25 | 53.13 | 59.07 | 46.30 | 1.428 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
09 Mon Dec 2024 | 49.84 | 53.00 | 53.97 | 49.83 | 0.054 times |
26 Tue Nov 2024 | 49.31 | 46.96 | 59.07 | 45.51 | 1.534 times |
31 Thu Oct 2024 | 46.39 | 47.00 | 50.50 | 44.44 | 1.167 times |
30 Mon Sep 2024 | 46.98 | 47.37 | 51.99 | 43.42 | 0.769 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.09 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.09 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.